|
Status |
Public on May 13, 2024 |
Title |
Tumor draining lymph node 2 |
Sample type |
SRA |
|
|
Source name |
Tumor-draining lymph node (inguinal)
|
Organism |
Mus musculus |
Characteristics |
tissue: Tumor-draining lymph node (inguinal) time: 4 weeks following induction agent: 4-hydroxy-tamxifen tumor induction cell type: Dendritic Cells genotype: BRafCA, PtenloxP, Tyr::CreERT2 strain: C57BL/6
|
Growth protocol |
B6.Cg-Tg(Tyr-cre/ERT2)13BosBraftm1MmcmPtentm1Hwu/BosJ mice from Jackson Lab were induced with 4HT on the back of the mice . Tumor were allowed to for 4 weeks at which point the inguinal TDLN or axillary non-draining LN was collected.
|
Extracted molecule |
polyA RNA |
Extraction protocol |
Lymph nodes were digested in collagenase and Dnase and DCs were collected by FACS sorting for Lin- Cd11c+ MHCIIhi cells Libraries were constructed using 10x Genomics default protocols following the Chromium 3' next gem gene expression v3.1
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic single cell |
Library selection |
cDNA |
Instrument model |
Illumina NextSeq 500 |
|
|
Description |
10x Genomics Next Gem Single Cell 3' Gene Expression
|
Data processing |
Sequencing was demultiplexed, the barcodes were identified and the genes were counted using the CellRanger 3.1 pipeline (https://www.10xgenomics.com/support/software/cell-ranger/release-notes/cr-release-notes) Assembly: mm10 Supplementary files format and content: tab seperated values and matrix files
|
|
|
Submission date |
Jan 18, 2024 |
Last update date |
May 13, 2024 |
Contact name |
Brent Hanks |
E-mail(s) |
brent.hanks@duke.edu
|
Organization name |
Duke University
|
Department |
Medicine
|
Street address |
308 Research Dr
|
City |
Durham |
State/province |
North Carolina |
ZIP/Postal code |
27710 |
Country |
USA |
|
|
Platform ID |
GPL19057 |
Series (2) |
GSE253592 |
A Lactate-induced SREBF2-dependent genetic program drives an immunotolerant dendritic cell population during cancer progression [scRNAseq_mouse] |
GSE253593 |
A Lactate-induced SREBF2-dependent genetic program drives an immunotolerant dendritic cell population during cancer progression |
|
Relations |
BioSample |
SAMN39489058 |
SRA |
SRX23306899 |